CRVS · Corvus Pharmaceuticals, Inc. · Analyst Estimates
Market Cap
$1.09B
Shares
84.12M
Analyst Estimates
Compare analyst forecasts for Corvus Pharmaceuticals, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.
Key facts
CIK
1626971
CUSIP
221015100
13F (30d)
61 filings
61 filers
Visit website
Investor relations